The convergence of rising health consciousness and the increasing adoption of GLP‑1 drugs has created a turning point for global diets. As drugs like semaglutide reshape eating habits by reducing appetite, consumers are leaning toward nutrient-dense, lower-calorie foods – a demand that plant-based products are uniquely placed to meet. This shift isn’t just about health; it’s reshaping markets. With 61% of Americans already increasing their protein intake and most planning to consume even more, the opport ...